MUC16 and pachyonychia congenita: Histologically expression of HA-tagged MUC16-Cter was confirmed both at the primary and metastatic sites, demonstrating that the expression of MUC16-Cter was maintained all through the process of formation of primary and metastatic PC in vivo (Supplemental Figures 3C and 3D).